Last year, UnitedHealth Group’s Optum announced plans to acquire Amedisys for $3.3 billion, facing scrutiny from the DOJ and the Oregon Health Authority. Amedisys recently disclosed a purchase agreement to sell certain home health care centers to VCG Luna. Experts believe the merger will likely go through, potentially with additional divestitures. Concerns about UHG’s growing influence in the healthcare system and its numerous acquisitions have been raised. While some see the merger as beneficial, others worry about UHG becoming too dominant. Despite uncertainties, many expect the merger to proceed, with potential implications for the healthcare industry as a whole.
Source link
Will A Divestiture Save the UnitedHealth Group-Amedisys Deal?
